Duopharma Biotech (KLSE:DPHARMA) detected an unauthorized attempt to gain access to its IT infrastructure, according to a Friday Bursa Malaysia filing.
After containing the incident, it was found that a set of data files had been exfiltrated.
The pharmaceutical manufacturer says its core corporate network and internal operational systems remain secure and functional, while a digital forensic investigation has already started.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.